• Mind
  • Body
  • Sight
  • Hearing
  • Smell
  • Taste
  • Touch
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Living with Scleroderma

Reflections on the Messy Complexity of Chronicity

  • Home
  • About
    • Privacy Policy
  • What Is Scleroderma?
  • Resources
  • Show Search
Hide Search

Big Pharma

Snake Eyes

Evelyn Herwitz · January 17, 2023 · 2 Comments

This is not a novel observation, but getting prescriptions filled for a reasonable cost in the U.S. is a crap shoot.

I just spent an hour on the phone with my Medicare Part D insurance company, trying to get prior authorization for a medication I need to refill every other month, but which is not covered by my plan. This, after first calling my pharmacy to find out why they kept sending me messages about an “insurance issue” with the prescription and then being told that they had not yet submitted the scrip and would only know details when it was filled. Now, none of that made sense, because in my app for the pharmacy, I could see the price—nearly $700.

But I need to back up. Because I have for the past several years very successfully been able to fill this scrip and one other very expensive medication via a Canadian online pharmacy in British Columbia. Great service, much more reasonable pricing. That is, however, until last month, when I received a letter from the FDA informing me that my other very expensive medication refill had been impounded at the Port of Los Angeles after being flagged by U.S. Customs.

The reason? Since this medication was available in the U.S., but it was coming from Canada, its authenticity could not be confirmed. To “protect” me from consumer fraud, the FDA was going to destroy it. I wrote to the official who sent the letter, trying to get an exemption, but no luck. And this particular medication would cost in the four figures if filled by my approved local pharmacy.

What to do? Thankfully, my team at Boston Medical suggested an alternative: Marc Cuban Cost Plus Drugs. This is a legitimate, licensed drug wholesaler that fills prescriptions at cost plus a 15 percent markup. And fortunately, they carry my very expensive medication. Here’s the kicker: the price from Canada was $200 for a refill; with Marc Cuban, $10! It arrived within a week and it works just fine, thank you very much.

Unfortunately, they do not as yet carry my other expensive medication, the one for which I await prior authorization. Even with insurance, I’m expected it to be pricey. Maybe there is an alternative, to be discussed with my medical provider, given that we have to wait until 2025 for the new $2,000 cap on Medicare drug out-of-pocket expenses to go into effect. Which assumes that this important provision of the new Inflation Reduction Act doesn’t get killed before then, given all the craziness in Washington.

The system is just so convoluted. And clearly, from the wholesale price for my very expensive medication, Big Pharma is just making a killing. (No news there.) Plus, who really has time or patience to dig for all the information needed to pursue prior authorization? I’m fortunate that I can take care of this for myself, that I own my own schedule at this point in my life, and we can afford the medications we need. Not so for too many others.

And so, after the hour on the phone with the prior authorization department at my Part D insurer, writing an email to my provider to let her know about the form they faxxed, and getting a voice mail from my Part D insurance telling my original request to fill the scrip was turned down (yes, I figured that out already), it’s a waiting game. Fingers crossed . . .

Evelyn Herwitz blogs weekly about living fully with chronic disease, the inside of baseballs, turtles and frogs, J.S. Bach, the meaning of life and whatever else she happens to be thinking about at livingwithscleroderma.com. Please view Privacy Policy here.

Image: David Clode

Share this:

  • Share
  • Email
  • Print
  • Facebook
  • Twitter
  • LinkedIn

Filed Under: Body, Hearing, Mind Tagged With: Big Pharma, managing chronic disease, Medicare Part D

Do Not Use If Allergic

Evelyn Herwitz · November 15, 2022 · 4 Comments

I am one of those people who still watch the news on cable, rather than solely on social media, streaming services, and other internet sources. And because I still watch the news on cable, I am part of the aging demographic that is bombarded with ads from drug companies.

There are ads for diabetes drugs that lower your A1C level, ads for drugs that supposedly prolong your life if you have advanced cancer, ads for drugs to relieve symptoms of autoimmune diseases like Crohn’s, ads for drugs to help manage asthma, ad nauseum. Perhaps all these drugs have their place, and if so, I hope they actually do some good for those who need them.

But I find the ads ridiculous. Inevitably, as images of happy folks living wonderful lives in loving relationships flash across the screen, accompanied by up-beat music, the voice-over ends the sales pitch with a laundry list (because they must, under FDA regulations for marketing directly to patients) of all the dire side effects that could happen. Why would you want to take a drug to manage bipolar disorder, to name just one example, if it could potentially make you feel suicidal? Isn’t the cure worse than the medical condition?

Of all the required warnings, however, the one that strikes me as most inane cautions the viewer not to take Drug X if you’re allergic to it. So, how do you know if you’re allergic to Drug X if you’ve never taken it?

Apparently only in America—and in New Zealand, it turns out—can drug companies peddle prescription drugs directly to easy marks, excuse me, potential patients. How fortunate for us. I suppose the strategy is if you push brand recognition, a patient would, of course, ask her physician to prescribe the particular miracle cure. Unless, of course, she listened to that long list of negative side effects.

The goal of this information overload is undoubtedly truth in advertising. A good thing. But when we only hear a litany of side effects, absent the evidence-based, actual risk of having a particular bad reaction to the drug, the information is basically useless.

I have a better idea. Just cut all drug ads for good, like we did years ago for tobacco products. The money that goes into making and placing these ad campaigns only hikes the cost of prescription drugs for the people who actually need them. It’s high time for Big Pharma’s marketing strategy, priming patient demand to push their pills to physicians, to go the way of the Marlboro Man and ride off into the sunset.

Evelyn Herwitz blogs weekly about living fully with chronic disease, the inside of baseballs, turtles and frogs, J.S. Bach, the meaning of life and whatever else she happens to be thinking about at livingwithscleroderma.com. Please view Privacy Policy here.

Image: Myriam Zilles

Share this:

  • Share
  • Email
  • Print
  • Facebook
  • Twitter
  • LinkedIn

Filed Under: Body, Hearing, Mind, Sight Tagged With: Big Pharma, managing chronic disease, resilience

Primary Sidebar

Subscribe via Email

Enter your email address to subscribe to Living With Scleroderma and receive new posts by email. Subscriptions are free and I never share your address.

About the Writer

When not writing about living fully with chronic health challenges, Evelyn Herwitz helps her marketing clients tell great stories about their good works. She would love to win a MacArthur grant and write fiction all day. Read More…

Blog Archive

Recent Posts

  • Anticipation
  • On Managing Pain
  • Oscillations
  • Candy Heart Wish
  • Soup’s On!

I am not a doctor . . .

. . . and don’t play one on TV. While I strive for accuracy based on my 40-plus years of living with scleroderma, none of what I write should be taken as medical advice for your specific condition.

Scleroderma manifests uniquely in each individual. Please seek expert medical care. You’ll find websites with links to medical professionals in Resources.

Copyright © 2023 · Daily Dish Pro on Genesis Framework · WordPress · Log in